Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,171
Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics
for
Obstructive Sleep Apnea
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 3 - 18
Code: NCT04991389
Recruiting
Down Syndrome Obstructive Sleep Apnea
for
Down Syndrome, Obstructive Sleep Apnea
Location: Cincinnati OH, Ann Arbor MI, Cleveland OH, Norfolk VA,
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 5 - 18
Code: NCT06043440
Phase2, Recruiting
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
for
Refractory Acute Myeloid Leukemia,
Location: Cincinnati OH, Atlanta GA, Memphis TN, Philadelphia PA,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 30
Code: NCT06177067
Phase1, Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
for
Uveitis
Location: Cincinnati OH, Kansas City KS, Boston MA
Sponsor: Meyer Children's Hospital IRCCS
Sex: All
Age: 1 - 16
Code: NCT06273748
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
for
Lower Respiratory Tract Infection, Parainfluenza,
Location: Cincinnati OH, Pittsburgh PA, Chicago IL, Durham NC,
Sponsor: Ansun Biopharma, Inc.
Sex: All
Age: 0+
Code: NCT03808922
Phase3, Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
for
Type 2 Diabetes
Location: Cincinnati OH, Indianapolis IN, Louisville KY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 10 - 17
Code: NCT06739122
Phase3, Recruiting
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
for
Fanconi Anemia, Severe Marrow Failure,
Location: Cincinnati OH, Seattle WA
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0+
Code: NCT02143830
Phase2, Recruiting
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
for
Autoimmune Liver Disease, Autoimmune Hepatitis,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 6 - 23
Code: NCT03178630
Recruiting
Comparing Stainless Steel Crowns With Prefabricated Resin Crowns in Primary Molar Teeth
for
Dental Caries
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 2 - 5
Code: NCT06713330
Recruiting
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
for
Attention Deficit Hyperactivity Disorder Combined
Location: Cincinnati OH, Baltimore MD
Sponsor: Donald Gilbert, MD, MS, FAAN, FAAP
Sex: All
Age: 8 - 12
Code: NCT04421248
Recruiting
MASA Valve Early Feasibility Study
for
Tetrology of Fallot, Pulmonary Stenosis, Truncus Arteriosus,
Location: Cincinnati OH, Peoria IL, Philadelphia PA, Boston MA,
Sponsor: PECA Labs
Sex: All
Age: 0 - 22
Code: NCT05452720
Recruiting
Protocol CAUSE-03 / CHEETAH
for
Asthma
Location: Cincinnati OH, Chicago IL, Washington D.C. DC,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 6 - 17
Code: NCT06136091
Recruiting
Study of Olutasidenib and Temozolomide in HGG
for
High Grade Glioma, Astrocytoma, Astrocytoma, Grade III,
Location: Cincinnati OH, Columbus OH, Chicago IL, Durham NC,
Sponsor: Rigel Pharmaceuticals
Sex: All
Age: 12 - 39
Code: NCT06161974
Phase2, Recruiting
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
for
Duchenne Muscular Dystrophy
Location: Cincinnati OH, Indianapolis IN, Chicago IL,
Sponsor: Catalyst Pharmaceuticals, Inc.
Sex: Male
Age: 2+
Code: NCT06564974
Recruiting
A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)